Lupus Nephritis News, Treatment Studies | SLE, Renal Disorders Treatment

SLE Flare Can Still Occur After Dialysis Initiation

October 6, 2022

In a study of 121 patients with lupus nephritis on dialysis, 26.4% experienced an SLE flare at a median of 17 months after dialysis initiation.

Nurse listening to heart of senior patient in medical clinic.

Incident Cardiovascular Disease Risk Up With Autoimmune Disease

October 6, 2022

Risk increased progressively with the number of autoimmune diseases present and with younger age

GAPSS Outperforms QRISK in Assessing Cardiovascular Disease Risk in Patients With SLE

September 29, 2022

Researchers compared the QRISK3 and the adjusted Global AntiPhospholipid Syndrome Score in patients with systemic lupus erythematosus to assess their risk of developing cardiovascular disease.

Reduction in Swollen, Tender Joints Greater With Litifilimab in Lupus

September 27, 2022

Most secondary end points did not support the results of the analysis for the primary end point

Kidney Failure Predictor in Lupus Nephritis Identified

September 26, 2022

Persistent isolated C3 hypocomplementemia is associated with an increased risk for end-stage kidney disease or death in patients with proliferative lupus nephritis, a study revealed.

medical technician gloved hand holding blood sample in tube

Metabolomics, Lipidomics Identify Systemic Lupus Erythematosus Biomarkers

August 26, 2022

Researchers sought to integrate serum metabolomics and lipidomics to identify biomarkers of organ involvement in systemic lupus erythematosus.

Novel Biomarkers for Diagnosing Systemic Lupus Erythematosus Detected in Plasma

August 25, 2022

Researchers evaluated the clinical value of miR-124-3p and miR-337-3p in plasma to determine whether they could serve as biomarkers for systemic lupus erythematosus.